Home › Peripheral T-Cell Lymphoma › Michigan
Peripheral T-Cell Lymphoma clinical trials in Michigan
4 studies for Peripheral T-Cell Lymphoma are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- University of Michigan, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07195916Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Michigan, Ann Arbor
- Barbara Ann Karmanos Cancer Institute Wayne State University, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04234048Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Roger Cancer Center University of Michigan Health, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Helen De Vos, Grand Rapids
RecruitingEarly phase 1
Ages 1 to 31 · All sexes · Updated Aug 18, 2026 · NCT03719105From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.